Our data suggest that an approach based on extending the intravenous multimodal analgesia after discharge has proven to be feasible and appropriate in a wide series of patients in our setting, and in ...
March 16, 2004 — An investigational fentanyl patient-controlled analgesia (PCA) transdermal system was found to provide postsurgical pain control equivalent to that of a standard intravenous (IV) ...
Predicting response to neoadjuvant chemoradiotherapy in esophageal cancer by textural features derived from pretreatment FDG-PET scans. Adjuvant chemotherapy with or without concurrent radiotherapy in ...
Facility-Level Disparities in Radiation Use for Limited-Stage Small Cell Lung Cancer Patient-controlled analgesia (PCA) has been considered for managing cancer pain; however, limited research has been ...
Olinvyk is indicated for short-term intravenous use in hospitals or other controlled clinical settings. The Food and Drug Administration (FDA) has approved Olinvyk (oliceridine; Trevena) for the ...
Avenue Therapeutics (ATXI) is developing IV tramadol for postoperative pain. The drug has been approved by the FDA since 1995; however, only in oral form. Avenue has licensed a patented administration ...
Announcing a new article publication for BIO Integration journal. In this article the authors Haojie Yang, Yingzhe Yan, Qian Xie and colleagues from Sun Yat-sen University, Guangzhou, China and The ...
LONDON, Feb. 5, 2024 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces the launch of COMBOGESIC® IV (acetaminophen and ibuprofen) injection in the ...
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces the launch of Combogesic IV (acetaminophen and ibuprofen) injection in the US. Combogesic IV is an intravenous, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results